FDA approves new type of therapy to treat advanced urothelial cancer
FDA granted accelerated approval to Padcev, indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer
Related Articles
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 7 – OncoDaily
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 7 / 100 Influential Women in Oncology, Alessandra Curioni,
Pfizer’s TALZENNA® in Combination with XTANDI® Prolongs Overall Survival in Phase 3 TALAPRO-2 Trial
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the final prespecified overall survival (OS) analysis of the TALAPRO-2 study of
Pfizer’s TALZENNA® in Combination with XTANDI® Prolongs Overall Survival in Phase 3 TALAPRO-2 Trial
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the final prespecified overall survival (OS) analysis of the TALAPRO-2 study of
Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce – PubMed
As the field of cancer immunotherapy continues to advance at a fast pace, treatment approaches and drug development are evolving rapidly to maximize patient benefit.…
Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce – PubMed
As the field of cancer immunotherapy continues to advance at a fast pace, treatment approaches and drug development are evolving rapidly to maximize patient benefit.…
Program Guide – ASCO Meeting Program Guide
Shilpa Gupta Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH Shilpa Gupta, Thomas Powles, Mairead Kearney, Laura Panattoni, Natalie Land, Thomas Flottemesch, Patrick Sullivan, Melissa Kirker,…
Program Guide – ASCO Meeting Program Guide
Shilpa Gupta Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH Shilpa Gupta, Thomas Powles, Mairead Kearney, Laura Panattoni, Natalie Land, Thomas Flottemesch, Patrick Sullivan, Melissa Kirker,…
PeerView – Candid Conversations on Modern Urothelial Cancer Management: Personalizing Patient Care Using the Latest Evidence and Innovative Therapeutic Strategies
See the latest #BladderCancer live event from @PeerView @AndreaNecchi #ASCO24 #MedEd
Urology Cancer Summit
The First International Urology Cancer Summit is a free and independent educational opportunity open to everyone involved in caring for patients with urologic cancers.
“Must See” Abstracts at 2024 ASCO Annual Meeting
Keep an eye out for these top research studies highlighted by Cleveland Clinic leadership.